Orthopaedic Oncology Service

COVID-19 UPDATE

To comply with current federal and state regulations regarding COVID-19, the Department of Orthopaedic Surgery has canceled all clinics and canceled all surgeries except those deemed urgent.

Orthopaedic Oncology Surgery and the Centers for Sarcoma and Chordoma have cancelled all routine clinic appointments. We continue to schedule urgent appointments such as postoperative patients requiring an in-person visit, infections, pathologic fractures, new patients with possible malignancies (cancer) and for continued radiation and chemotherapy treatments. All patients will be screened on the phone and upon entering clinics for cough, shortness of breath, fever, and nausea/vomiting/diarrhea. Providers will then determine the best course of action for patients who present with COVID-19 symptoms.

All patients (new or established) can make a virtual visit appointment or phone call with our providers. Call the main number: 617-724-3700, follow the voice prompts to reach the new patient coordinator, your surgeon’s assistant, or the Clinical Director, DNP Anne Fiore.

New patients must register (1-866-211-6588) before an any appointment can be made. And you must enroll in Patient Gateway in order to have a virtual visit.

We want you to know that your Orthopaedic Oncology surgeons (Raskin, Lozano, Newman), DNP Fiore, Medical Oncologists (Choy, Cote), Radiation Oncologists (Delaney, Chen) and Surgical Oncologist (Mullen) remain with you and your family during this COVID-19 emergency. We are all available to answer/address any concerns you may have.

Unfortunately, we do not know when hospital operations will return to normal to reschedule postponed surgeries and clinic visits. We will notify you as soon as possible. Until then follow federal, state and CDC guidelines. We appreciate your patience and understanding as we all proceed together through this COVID-19 situation.


Compassionate, Multidisciplinary Treatment

For more than 45 years, the Mass General Orthopaedic Oncology Service has treated children, adolescents and adults with primary bone and soft tissue tumors (benign and malignant) and metastatic disease.

Bone and soft tissue sarcomas are among the rarest malignant tumors treated. There are approximately 3,000 new cases of primary bone tumors each year, which accounts for less than 0.2% of all adult cancer cases. And there are approximately 13,000 new primary soft tissue tumors each year, which account for 1% of all adult cancer cases. Because of this, we take a comprehensive approach to treating these rare tumors, incorporating every resource the hospital has to offer to ensure our patients receive the best and most current treatment available.

Treatment plans are coordinated through our team approach and includes orthopaedic oncology surgeons, radiation oncologists, medical oncologists, pathologists, radiologists and nurse practitioners. Medical and surgical experts work together seamlessly to provide treatment programs that are individually designed for each patient. We carefully assess outcomes and take pride in making it possible for our patients to live their lives as fully as possible.



Patient Resources

An icon representing patient resources
Conditions & Treatments

Conditions & Treatments

Our comprehensive patient education hub created by our clinicians for our patients.

An icon representing research
Harris Center for Chordoma Care

Harris Center for Chordoma Care

A multidisciplinary center created to support chordoma patients.

An icon representing patient education
ICAN: Amputee Network

ICAN: Amputee Network

A new collaboration with orthopaedic surgeons, plastic surgeons and rehab specialists.